{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:16:25Z","timestamp":1793751385833,"version":"4.6.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/hjh.0b013e32835fdf60","type":"journal-article","created":{"date-parts":[[2013,3,22]],"date-time":"2013-03-22T22:32:24Z","timestamp":1363991544000},"page":"1245-1255","source":"Crossref","is-referenced-by-count":11,"title":["Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial"],"prefix":"10.1097","volume":"31","author":[{"given":"Nobuyuki","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Sasagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naofumi","family":"Takehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Sumitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210208","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1291\/hypres.29.143","article-title":"Current status of antihypertensive prescription and associated blood pressure control in Japan.","volume":"29","author":"Mori","year":"2006","journal-title":"Hypertens Res"},{"key":"R3-27-20210208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/hr.2009.34","article-title":"The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009).","volume":"32","author":"Ogihara","year":"2009","journal-title":"Hypertens Res"},{"key":"R4-27-20210208","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"2007 Guidelines for the Management of Arterial Hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"R5-27-20210208","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jash.2010.02.005","article-title":"American Society of Hypertension Writing Group. Combination therapy in hypertension.","volume":"4","author":"Gradman","year":"2010","journal-title":"J Am Soc Hypertens"},{"key":"R6-27-20210208","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"},{"key":"R7-27-20210208","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","article-title":"ACCOMPLISH Trial investigators. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomized controlled trial.","volume":"375","author":"Mancia","year":"2010","journal-title":"Lancet"},{"key":"R8-27-20210208","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ki.2008.102","article-title":"GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.","volume":"73","author":"Bakris","year":"2008","journal-title":"Kidney Int"},{"key":"R9-27-20210208","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0895-7061(95)00213-9","article-title":"Age is a major determinant of the divergent blood pressure responses to varying salt intake in essential hypertension.","volume":"8","author":"Overlack","year":"1995","journal-title":"Am J Hypertens"},{"key":"R10-27-20210208","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"R11-27-20210208","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1474-4422(08)70143-1","article-title":"HYVET Investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.","volume":"7","author":"Peters","year":"2008","journal-title":"Lancet Neurol"},{"key":"R12-27-20210208","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/01.STR.0000196941.58869.2d","article-title":"Midlife pulse pressure and incidence of dementia: the Honolulu-Asia Aging Study.","volume":"37","author":"Freitag","year":"2006","journal-title":"Stroke"},{"key":"R13-27-20210208","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0197-4580(00)00259-1","article-title":"Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimers dementia.","volume":"22","author":"Savaskan","year":"2001","journal-title":"Neurobiol Aging"},{"key":"R14-27-20210208","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis.","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"R15-27-20210208","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00063-008-1073-4","article-title":"Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study).","volume":"103","author":"Schrader","year":"2008","journal-title":"Med Klin (Munich)"},{"key":"R16-27-20210208","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.jhh.1001613","article-title":"Influence of losartan and atenolol on memory function in very elderly hypertensive patients.","volume":"17","author":"Fogari","year":"2003","journal-title":"J Hum Hypertens"},{"key":"R17-27-20210208","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1212\/01.WNL.0000140705.23869.E9","article-title":"Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression.","volume":"63","author":"Ohrui","year":"2004","journal-title":"Neurology"},{"key":"R18-27-20210208","doi-asserted-by":"crossref","first-page":"e16037","DOI":"10.1371\/journal.pone.0016037","article-title":"Central angiotensin II stimulation promotes amyloid production in Sprague Dawley rats.","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"key":"R19-27-20210208","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/rej.2009.0944","article-title":"Protective effects of intranasal losartan in the APPPS1 transgenic mouse model of Alzheimer disease.","volume":"13","author":"Danielyan","year":"2010","journal-title":"Rejuvenation Res"},{"key":"R20-27-20210208","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1536\/ihj.53.244","article-title":"for the CAMUI investigatorsCombination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial: rationale and design.","volume":"53","author":"Sato","year":"2012","journal-title":"Int Heart J"},{"key":"R21-27-20210208","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan.","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R22-27-20210208","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1291\/hypres.30.831","article-title":"Effectiveness of add-on low-dose diuretics in combination therapy for hypertension: losartanhydrochlorothiazide vs. candesartanamlodipine.","volume":"30","author":"Shimosawa","year":"2007","journal-title":"Hypertens Res"},{"key":"R23-27-20210208","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/hr.2010.233","article-title":"Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension.","volume":"34","author":"Kato","year":"2011","journal-title":"Hypertens Res"},{"key":"R24-27-20210208","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(04)16456-8","article-title":"Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trail.","volume":"363","author":"Weber","year":"2004","journal-title":"Lancet"},{"key":"R25-27-20210208","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"R26-27-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"R27-27-20210208","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts.","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"R28-27-20210208","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"R29-27-20210208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2215\/CJN.00840805","article-title":"Lessons learned from recent hypertension trials about kidney disease.","volume":"1","author":"Khosla","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R30-27-20210208","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with nondiabetic chronic renal disease (REIN-2): multicentre, randomized controlled trial.","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"R31-27-20210208","first-page":"685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern Arch Intern M","volume":"160","author":"Bakris","year":"2000","journal-title":"ed"},{"key":"R32-27-20210208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-151-1-200907070-00122","article-title":"Effect of telmisartan on renal outcomes: a randomized trial.","volume":"151","author":"Mann","year":"2009","journal-title":"Ann Intern Med"},{"key":"R33-27-20210208","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2337\/dc06-0248","article-title":"Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.","volume":"29","author":"So","year":"2006","journal-title":"Diabetes Care"},{"key":"R34-27-20210208","first-page":"1140","article-title":"Composite renal endpoints: was ACCOMPLISH accomplished L","volume":"375","author":"Heerspink","year":"2010","journal-title":"ancet"},{"key":"R36-27-20210208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000072054","article-title":"Role of actions of calcium antagonists on efferent arteries: with special references to glomerular hypertension.","volume":"23","author":"Hayashi","year":"2003","journal-title":"Am J Nephrol"},{"key":"R37-27-20210208","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Chronic Kidney Disease Prognosis Consortium, Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"R38-27-20210208","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.111.171488","article-title":"Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in noninsulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial.","volume":"58","author":"Miao","year":"2011","journal-title":"Hypertension"},{"key":"R39-27-20210208","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1291\/hypres.31.295","article-title":"Efficacy and safety of long-term losartan therapy demonstrated by a prospective observational study in Japanese patients with hypertension: The Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study.","volume":"31","author":"Naritomi","year":"2008","journal-title":"Hypertens Res"},{"key":"R40-27-20210208","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.","volume":"5","author":"Goicoechea","year":"2010","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-201306000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T02:10:15Z","timestamp":1618366215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201306000-00027"}},"subtitle":["results after 1 year"],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e32835fdf60","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}